Occurrence of HAEC · children with Hirschsprung's disease (HD)
It is very uncertain whether probiotics changes occurrence of HAEC compared with placebo (very low certainty).
1 finding from 1 review
Serious adverse events · children with Hirschsprung's disease (HD)
1 finding from 1 review
Severity of HAEC Â · children with Hirschsprung's disease (HD)
Probiotics showed no clear difference in severity of HAEC Â compared with placebo (low certainty).
1 finding from 1 review
Overall mortality · children with Hirschsprung's disease (HD)
1 finding from 1 review
Withdrawals due to adverse events · children with Hirschsprung's disease (HD)
1 finding from 1 review
Recurrent episodes of HAEC · children with Hirschsprung's disease (HD)
Probiotics showed no clear difference in recurrent episodes of HAEC compared with placebo (low certainty).
1 finding from 1 review
Global improvement or treatment success, as defined by primary study · children with chronic constipation without a physical explanation
It is very uncertain whether probiotics changes global improvement/treatment success, as defined by the primary study compared with magnesium oxide (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · children with chronic constipation without a physical explanation
It is very uncertain whether probiotics changes withdrawals due to adverse events compared with magnesium oxide (very low certainty).
1 finding from 1 review
Serious adverse events · children with chronic constipation without a physical explanation
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · children with chronic constipation without a physical explanation
1 finding from 1 review
Clinical remission · people with active UC
Probiotics may leads to higher clinical remission compared with placebo (low certainty).
1 finding from 1 review
Disease improvement · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease improvement (based on clinical scores) · people with active UC
Probiotics may leads to higher disease improvement (based on clinical scores) compared with placebo (low certainty).
1 finding from 1 review
Minor adverse events · people with active UC
It is very uncertain whether probiotics changes minor adverse events compared with placebo (very low certainty).
1 finding from 1 review
Serious adverse events · people with active UC
It is very uncertain whether probiotics changes serious adverse events compared with placebo (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with active UC
Probiotics showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Clinical remission · people with active UC
Probiotics showed no clear difference in clinical remission compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (low certainty).
1 finding from 1 review
Minor adverse events · people with active UC
It is very uncertain whether probiotics changes minor adverse events compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).
1 finding from 1 review
Serious adverse events · people with active UC
It is very uncertain whether probiotics changes serious adverse events compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with active UC
It is very uncertain whether probiotics changes withdrawal due to adverse events compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).
1 finding from 1 review